Skip to main content
SpringerLink
Log in

Okuläre Beteiligung bei Stevens-Johnson-Syndrom (SJS) und Toxisch epidermaler Nekrolyse (TEN) (engl. Stevens-Johnson syndrome, SJS, and toxic epidermal necrolysis, TEN)

  • Chapter
  • First Online:
Entzündliche Augenerkrankungen

  • 1316 Accesses

Zusammenfassung

ICD-10-Code L12 Pemphigoiderkrankungen, L51.1 Erythema exsudativum multiforme; Stevens-Johnson-Syndrom; Toxisch epidermale Nekrolyse

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Araki Y, Sotozono C, Inatomi T, Ueta M, Yokoi N, Ueda E, Kishimoto S, Kinoshita S (2009) Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 147(6):1004–1011

    Article  CAS  PubMed  Google Scholar 

  • Arévalo JM, Lorente JA, González-Herrada C, Jiménez-Reyes J (2000) Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma 48:473–478

    Article  PubMed  Google Scholar 

  • Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149–153

    Article  CAS  PubMed  Google Scholar 

  • Basu S, Pillai VS, Sangwan VS (2013) Mucosal complications of modified osteoodonto keratoprosthesis in chronic Stevens–Johnson syndrome. Am J Ophthalmol 156:867–873.e2

    Article  PubMed  Google Scholar 

  • Basu S, Shanbhag SS, Gokani A, Kedar R, Bahuguna C, Sangwan VS (2018) Chronic ocular sequelae of stevens-johnson syndrome in children: long-term impact of appropriate therapy on natural history of disease. Am J Ophthalmol 189:17–28

    Article  PubMed  Google Scholar 

  • Bohm KJ, Ciralsky JB, Harp JL, Bajaj S, Sippel KC (2016) Cicatrizing conjunctivitis in a patient diagnosed with drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome but with features of stevens-johnson syndrome. Cornea 35:888–891

    Article  PubMed  Google Scholar 

  • Catt CJ, Hamilton GM, Fish J et al (2016) Ocular manifestations of Stevens–Johnson syndrome and toxic epidermal necrolysis in children. Am J Ophthalmol 166:68–75

    Article  PubMed  Google Scholar 

  • Chung WH, Hung SI et al (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14(12):1343–1350

    Article  CAS  PubMed  Google Scholar 

  • Creamer D, Walsh SA, Dziewulski P et al (2016) U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. Br J Dermatol 174:1194–1227

    Article  CAS  PubMed  Google Scholar 

  • De La Paz MF, De Toledo JA, Charoenrook V et al (2011) Impact of clinical factors on the long-term functional and anatomic outcomes of osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis. Am J Ophthalmol 151:829–839.e1

    Article  Google Scholar 

  • De Rojas MV, Dart JK et al (2007) The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol 91(8):1048–1053

    Article  PubMed  PubMed Central  Google Scholar 

  • Faye O, Roujeau JC (2005) Treatment of epidermal necrolysis with high-dose intravenous im-munoglobulins (IVIG). Clinical experience to date. Drugs 65(15):2085–2090

    Article  CAS  PubMed  Google Scholar 

  • González-Herrada C, Rodríguez-Martín S, Cachafeiro L et al (2017) Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J Invest Dermatol 137:2092–2100

    Article  PubMed  Google Scholar 

  • Gregory DG (2016) New grading system and treatment guidelines for the acute ocular manifestations of stevens-johnson syndrome. Ophthalmology 123:1653–1658

    Article  PubMed  Google Scholar 

  • Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M (2009). Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 145(2):157–162.

    Google Scholar 

  • Gungor I, Schor K et al (2008) The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS 12(3):263–267

    Article  PubMed  Google Scholar 

  • Haber J, Hopman W et al (2005) Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center. J Burn Care Rehabil 26(1):33–41

    Article  PubMed  Google Scholar 

  • Huang Y-C, Li Y-C, Chen T-J (2012) The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol 167:424–432

    Article  CAS  PubMed  Google Scholar 

  • Iyer G, Pillai VS, Srinivasan B et al (2010) Mucous membrane grafting for lid margin keratinization in Stevens–Johnson syndrome: results. Cornea 29:146–151

    Article  PubMed  Google Scholar 

  • Iyer G, Srinivasan B, Agarwal S et al (2014) Comprehensive approach to ocular consequences of Stevens Johnson Syndrome – the aftermath of a systemic condition. Graefes Arch Clin Exp Ophthalmol 252:457–467

    Article  PubMed  Google Scholar 

  • Iyer G, Srinivasan B, Agarwal S et al (2016) Treatment modalities and clinical outcomes in ocular sequelae of Stevens–Johnson syndrome over 25 years – a paradigm shift. Cornea 35:46–50

    Article  PubMed  Google Scholar 

  • Jain R, Sharma N, Basu S, Iyer G (2016) Stevens-Johnson syndrome: the role of an ophthalmologist. Surv Ophthalmol 61:369–399

    Article  PubMed  Google Scholar 

  • Kim DH, Yoon KC, Seo KY et al (2015) The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens–Johnson syndrome. Ophthalmology 122:254–264

    Article  PubMed  Google Scholar 

  • Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP (2014) Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol 71:941–947

    Article  CAS  PubMed  Google Scholar 

  • Kohanim S, Palioura S, Saeed HN et al (2016) Acute and chronic ophthalmic involvement in Stevens–Johnson syndrome/toxic epidermal necrolysis – a comprehensive review and guide to therapy. II Ophthalmic disease Ocul Surf 14:168–188

    Article  PubMed  Google Scholar 

  • Kuper K, Pleyer U et al (1995) Erythema exsudativum multiforme major. Ophthalmologe 92(6):823–828

    CAS  PubMed  Google Scholar 

  • Lee HY, Lim YL, Thirumoorthy T, Pang SM (2013) The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre. Br J Dermatol 169:1304–1309

    Article  CAS  PubMed  Google Scholar 

  • Lonjou C, Thomas L et al (2006) A marker for Stevens-Johnson syndrome …: ethnicity matters. Pharm J 6(4):265–268

    CAS  Google Scholar 

  • Lonjou C, Thomas L et al (2006) A marker for Stevens-Johnson syndrome …: ethnicity matters. Pharm J 6(4):265–268

    CAS  Google Scholar 

  • Lonjou C, Borot N et al (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18(2):99–107

    Article  CAS  PubMed  Google Scholar 

  • Ma KN et al (2016) A novel technique for amniotic membrane transplantation in patients with acute Stevens-Johnson syndrome. Ocul Surf 14:31–36

    Article  PubMed  Google Scholar 

  • Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7(6):814–815

    Article  Google Scholar 

  • Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7(6):814–815

    Article  Google Scholar 

  • Mockenhaupt M, Roujeau JC (2019) Epidermal Necrolysis (Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis DJ, McMichael AJ, Orringer JS (Hrsg) Fitzpatrick’s dermatology, 9. Aufl. McGraw Hill Education, S 733–748, chapt. 44

    Google Scholar 

  • Mockenhaupt M, Viboud C et al (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128(1):35–44

    Article  CAS  PubMed  Google Scholar 

  • Paulmann M, Mockenhaupt M (2019) Schwere Hautreaktionen: klinisches Bild, Epidemiologie, Ätiologie, Pathogenese und Therapie. Allergo J Int 28:311–326

    Article  Google Scholar 

  • Oplatek A, Brown K et al (2006) Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res 27(1):26

    Article  PubMed  Google Scholar 

  • Ong HS, Minassian D, Rauz S, Mehta JS, Dart JK (2019) Validation of a clinical assessment tool for cicatrising conjunctivitis. Ocul Surf pii: S1542-0124(19):30210–30211

    Google Scholar 

  • Papakostas TD, Le HG, Chodosh J, Jacobs DS (2015) Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens–Johnson syndrome/toxic epidermal necrolysis. Ophthalmology 122:248–253

    Article  PubMed  Google Scholar 

  • Paulmann M, Kremmler C, Sekula P, Valeyrie-Allanore L, Naldi L, Kardaun S, Mockenhaupt M for the RegiSCAR Group (2016) Long-term sequelae in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis: a 5-year analysis. Allergy (Journal of the European Academy of Allergy and Clinical Immunology (EAACI)), link BioMedCentral platform 3.

    Google Scholar 

  • Quinto GG, Campos M et al (2008) Autologous serum for ocular surface diseases. Arq Bras Oftalmol 71(6):47–54

    Article  PubMed  Google Scholar 

  • Romero-Rangel T, Stavrou P et al (2000) Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol 130(1):25–32

    Article  CAS  PubMed  Google Scholar 

  • Rootman DB, Kim MJ, Aldave AJ et al (2015) Ocular surface, fornix, and eyelid rehabilitation in Boston type I keratoprosthesis patients with mucous membrane disease. Ophthal Plast Reconstr Surg 31:43–49

    Article  PubMed  Google Scholar 

  • Roujeau JC, Huynh TN et al (1987) Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 123(9):1171–1173

    Article  CAS  PubMed  Google Scholar 

  • Roujeau JC, Mockenhaupt M, Guillaume JC, Revuz J (2017) New evidence supporting cyclosporine efficacy in epidermal necrolysis. J Invest dermatol 137:2047–2049

    Article  CAS  PubMed  Google Scholar 

  • Roujeau JC, Mockenhaupt M (2019) Erythema multiforme. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis DJ, McMichael AJ, Orringer JS (Hrsg) Fitzpatrick’s dermatology, 9. Aufl. McGraw Hill Education, S 723–732, chapt. 43

    Google Scholar 

  • Roujeau JC, Phlippoteau C et al (1985) Sjögren-like syndrome after drug-induced toxic epidermal necrolysis. Lancet 1(8429):609–611

    Article  CAS  PubMed  Google Scholar 

  • Rzany B, Mockenhaupt M et al (1996) Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. J Clin Epidemiol 49(7):769–773

    Article  CAS  PubMed  Google Scholar 

  • Saeed HN, Rashad R (2020) Ocular disease in Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Colby K, Dana R (Hrsg) Foundations of corneal disease. Springer, Berlin, Heidelberg S 97–108

    Google Scholar 

  • Sharma N, Thenarasun SA, Kaur M et al (2016) Adjuvant role of amniotic membrane transplantation in acute ocular Stevens–Johnson syndrome: a randomized control trial. Ophthalmology 123:484–491

    Article  PubMed  Google Scholar 

  • Sotozono C, Ueta M, Nakatani E et al (2015) Japanese Research committee on severe cutaneous adverse reaction. Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol 160:228–237

    Article  PubMed  Google Scholar 

  • Sotozono C, Ueta M, Yokoi N (2018) Severe dry eye with combined mechanisms is involved in the ocular sequelae of SJS/TEN at the chronic stage. Invest Ophthalmol Vis Sci 59:DES80–DES86

    Article  CAS  PubMed  Google Scholar 

  • Su S-C, Mockenhaupt M, Wolkenstein P et al (2017) Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome/toxic epidermal necrolysis. J Invest Dermatol 137:1065–1073

    Article  CAS  PubMed  Google Scholar 

  • Tougeron-Brousseau B, Delcampe A et al (2009) Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol 148(6):852–859

    Article  PubMed  Google Scholar 

  • Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maître B, Revuz J, Bagot M, Roujeau JC (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163:847–853

    Article  CAS  PubMed  Google Scholar 

  • Wang C-W, Yang L-Y, Chen C-B et al (2018) Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest 128:985–996

    Article  PubMed  PubMed Central  Google Scholar 

  • Weber SL, de Souza RB, Gomes JA, Hofling-Lima AL (2016) The use of the esclera scleral contact lens in the treatment of moderate to severe dry eye disease. Am J Ophthalmol 163:167–173.e1

    Article  Google Scholar 

  • White KD, Abe R, Ardern-Jones M et al (2018) Special Article: SJS/TEN 2017: building multidisciplinary networks to drive science and translation. J Allergy Clin Immunol Pract 6(1):38–69

    Article  PubMed  PubMed Central  Google Scholar 

  • Wolkenstein P, Latarjet J, Roujeau JC et al (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet Lond Engl 352:1586–1589

    Article  CAS  Google Scholar 

  • Yang CW, Cho YT, Chen KL, Chen YC, Song HL, Chu CY (2016) Long-term sequelae of stevens-johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 96(4):525–529

    Article  CAS  PubMed  Google Scholar 

  • Ziemer M, Mockenhaupt M (2011) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. Skin Biopsy - Perspect. https://doi.org/10.5772/22335

  • Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, Mockenhaupt M (2017) Systemic immunomodulating therapies for stevens-johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 153:514–522

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum Ludwigshafen, Klinik für Augenheilkunde, Ludwigshafen am Rhein, Deutschland

    Argyrios Chronopoulos

  2. Dokumentationszentrum schwerer Hautreaktionen (dZh), Klinik für Dermatologie und Venerologie, Universitätsklinikum Freiburg, Freiburg, Deutschland

    Maja Mockenhaupt

  3. Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Berlin Charité Campus Virchow-Klinikum, Berlin, Deutschland

    Uwe Pleyer

Authors
  1. Argyrios Chronopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maja Mockenhaupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uwe Pleyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Argyrios Chronopoulos .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Berlin Charité Campus Virchow-Klinikum, Berlin, Deutschland

    Uwe Pleyer

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chronopoulos, A., Mockenhaupt, M., Pleyer, U. (2021). Okuläre Beteiligung bei Stevens-Johnson-Syndrom (SJS) und Toxisch epidermaler Nekrolyse (TEN) (engl. Stevens-Johnson syndrome, SJS, and toxic epidermal necrolysis, TEN). In: Pleyer, U. (eds) Entzündliche Augenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60399-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-60399-4_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-60398-7

  • Online ISBN: 978-3-662-60399-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation